Delivery Order SPE2DE21D7020-SPE2D623F5EW5

Award Date 8/1/23
Potential Completion Date 8/8/23
Potential Value $4.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,794.40 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a leading manufacturer of medical devices. The contract is for the delivery of the ELUVIA Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of August 28, 2024 and does not have a set-aside designation. Boston Scientific is an experienced federal contractor, having received numerous contracts and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices. The $21,316.72 fixed-price contract is for the Eluvia Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of December 12, 2024. Boston Scientific is the prime contractor and sole provider for this award, which is not associated with a set-aside program. The contract builds on Boston...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a global medical technology company based in Marlborough, Massachusetts. The contract, valued at $42,312.11, is for the procurement of the ELUVIA Drug Eluting Stent, a specialized cardiovascular medical device. The contract is a fixed-price with economic price adjustment and has an ultimate completion date of March 20, 2025. This award is not associated with a set-aside program. Boston...
This is a federal delivery order contract awarded by the Defense Health Agency (DHA) to Boston Scientific Corporation, doing business as Boston Scientific, a leading manufacturer of medical devices. The contract, with a ceiling value of $12,241.35, is for the delivery of Eluvia Drug Eluting Stents, a specialized cardiovascular medical device. The contract has a fixed-price with economic price adjustment pricing type and a completion date of July 17, 2024. Boston Scientific is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, doing business as Boston Scientific, for the supply of Eluvia Drug Eluting Stents. The contract has a ceiling value of $19,894.22 and an ultimate completion date of September 27, 2024. It is not set aside for any specific socioeconomic program. Boston Scientific is a leading manufacturer of medical devices that provides innovative, minimally invasive solutions to federal healthcare...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading medical device manufacturer, for the supply of the ELUVIA Drug Eluting Stent. The contract has a ceiling value of $8,464.00 and an ultimate completion date of September 12, 2024. The contract is a fixed-price with economic price adjustment and is not set aside. Boston Scientific, doing business as Boston Scientific, is the prime contractor and the manufacturer of...
The Defense Logistics Agency Troop Support Medical awarded a $2,002 delivery order to Boston Scientific Corporation for WALLSTENTS under contract number 4561799365. As the prime contractor, Boston Scientific will provide medical devices from its Marlborough, Massachusetts location to fulfill the agency's requirements. The fixed price with economic price adjustment contract runs from August 14-21, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a global medical technology company. The contract is for the procurement of Eluvia Drug Eluting Stents, which are specialized cardiovascular devices. The contract has a ceiling value of $107,249.09 and a performance period through January 30, 2025. This award does not utilize any set-aside designations. Boston Scientific, as the prime contractor, will be responsible for providing the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation for the procurement of the Eluvia Drug Eluting Stent, a medical device. The contract has a total ceiling value of $8,464.00 and is set to expire on September 19, 2024. The contract is a fixed-price with economic price adjustment arrangement. This order is part of a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle that Boston Scientific holds with the Department of...
The Defense Logistics Agency Troop Support Medical awarded a $240,100 fixed-price with economic price adjustment delivery order to Boston Scientific Corporation, doing business as Boston Scientific, for medical supplies. The prime contractor Boston Scientific will provide the requested products and services from their place of performance in Marlborough, Massachusetts. The one-week period of performance for this delivery order is July 21, 2023 through July 28, 2023. As a leading medical device...
  • SPE2DE21D7020
    Indefinite Delivery Contract
  • SPE2DE21D7020-SPE2D623F5EW5
    Delivery Order

The Defense Logistics Agency Troop Support Medical awarded a $4,232 fixed-price delivery order to Boston Scientific Corporation, doing business as Boston Scientific, for the delivery of ELUVIA drug-eluting stents. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Boston Scientific to provide the stents to the agency between August 1-8, 2023. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts. No subcontractors or set-aside designations were identified. The stents will support the Defense Logistics Agency's medical supply chain initiatives to equip military treatment facilities with important medical technologies.

Generated 12/24/23, 3:05 PM